Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24363961 | 0.81 | PRMT5 (0.49) | PRMT5WDR77 | |
| SCHEMBL29325719 | 0.81 | PRMT5 (0.49) | PRMT5WDR77 | |
| SCHEMBL24363963 | 0.69 | PRMT5 (0.58) | PRMT5WDR77 | |
| SCHEMBL30470835 | 0.67 | — | — | |
| SCHEMBL24366042 | 0.60 | PRMT5 (0.62) | PRMT5WDR77 | |
| SCHEMBL6232352 | 0.60 | RAB9A (0.31) | — | |
| SCHEMBL10518818 | 0.58 | PARP1 (0.34) | — | |
| SCHEMBL29338266 | 0.56 | — | — | |
| SCHEMBL25321483 | 0.56 | PRMT5 (0.37) | PRMT5WDR77 | |
| SCHEMBL25322761 | 0.56 | PRMT5 (0.37) | PRMT5WDR77 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240228478-A1 | COMPOUNDS AND METHODS OF USE | TANGO THERAPEUTICS, INC. | 2024-07-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240228478-A1 | COMPOUNDS AND METHODS OF USE | F12, C1R, ABCG2 | PRMT5 347/4885WDR77 1263/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.